Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients. [electronic resource] by
- Genovese, M C
- Breedveld, F C
- Emery, P
- Cohen, S
- Keystone, E
- Matteson, E L
- Baptiste, Y
- Chai, A
- Burke, L
- Reiss, W
- Sweetser, M
- Shaw, T M
Producer: 20091231
In:
Annals of the rheumatic diseases vol. 68
Availability: No items available.
|
|
12.
|
Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%). [electronic resource] by
- Ballow, M
- Berger, M
- Bonilla, F A
- Buckley, R H
- Cunningham-Rundles, C H
- Fireman, P
- Kaliner, M
- Ochs, H D
- Skoda-Smith, S
- Sweetser, M T
- Taki, H
- Lathia, C
Producer: 20031223
In:
Vox sanguinis vol. 84
Availability: No items available.
|
|
13.
|
A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. [electronic resource] by
- Lee, P P
- Fitzpatrick, D R
- Beard, C
- Jessup, H K
- Lehar, S
- Makar, K W
- Pérez-Melgosa, M
- Sweetser, M T
- Schlissel, M S
- Nguyen, S
- Cherry, S R
- Tsai, J H
- Tucker, S M
- Weaver, W M
- Kelso, A
- Jaenisch, R
- Wilson, C B
Producer: 20011227
In:
Immunity vol. 15
Availability: No items available.
|